On Nov 3, 2021 ANI Pharmaceuticals closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: ANI Pharmaceuticals […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series B – Prilenia
On Nov 3, 2021 Prilenia closed a Series B round and raised $43,000,000 from ALS Investment Fund, Amplitude Venture Capital, Forbion Capital Partners, Morningside Venture […]
Post-IPO Equity – ANI Pharmaceuticals
On Nov 3, 2021 ANI Pharmaceuticals closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: ANI Pharmaceuticals […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series A – Dunad Therapeutics
On Nov 2, 2021 Dunad Therapeutics closed a Series A round and raised $24,000,000 from BioGeneration Ventures, Epidarex Capital, Novartis, featuring lead investors BioGeneration Ventures. […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Post-IPO Equity – NovaBay Pharmaceuticals
On Nov 1, 2021 NovaBay Pharmaceuticals closed a Post-IPO Equity round and raised $15,000,000 from investors, featuring lead investors . About the company: NovaBay Pharmaceuticals […]
Grant – Mustang Bio
On Nov 1, 2021 Mustang Bio closed a Grant round and raised $2,000,000 from National Institutes of Health, featuring lead investors . About the company: […]
Grant – InterveXion Therapeutics
On Nov 1, 2021 InterveXion Therapeutics closed a Grant round and raised $13,800,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
